X-CLX-Shades: |
MLX |
X-CLX-Response: |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 |
Date: |
Wed, 13 Sep 2023 15:10:42 +0200 |
Reply-To: |
|
Approved-By: |
|
Message-ID: |
|
MIME-Version: |
1.0 |
Subject: |
|
Emisor: |
|
Received: |
by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 17.0) with spool id
7924883 for [log in para visualizar]; Wed, 13 Sep 2023
15:13:10 +0200
from mx07-006a4e02.pphosted.com (mx07-006a4e02.pphosted.com
[143.55.146.78]) by listserv.backend.rediris.es (Postfix) with ESMTP
id 6918E29007C for < [log in para visualizar]>; Wed, 13 Sep
2023 15:10:47 +0200 (CEST)
from pps.filterd (m0316689.ppops.net [127.0.0.1]) by
m0316689.ppops.net (8.17.1.22/8.17.1.22) with ESMTP id 38DD1d7M022617
for < [log in para visualizar]>; Wed, 13 Sep 2023 15:10:47 +0200
from satellite02.sim.rediris.es (satellite02.sim.rediris.es
[130.206.24.61]) by m0316689.ppops.net (PPS) with ESMTPS id
3t2y8w8wjj-1 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384
bits=256 verify=NOT) for < [log in para visualizar]>; Wed, 13
Sep 2023 15:10:46 +0200 (MEST)
from satellite02.sim.rediris.es (localhost.localdomain [127.0.0.1])
by satellite02.sim.rediris.es (Postfix) with ESMTPS id 79BBB8039EB
for < [log in para visualizar]>; Wed, 13 Sep 2023 15:10:45
+0200 (CEST)
from localhost (localhost.localdomain [127.0.0.1]) by
satellite02.sim.rediris.es (Postfix) with ESMTP id 4B643925E01 for
< [log in para visualizar]>; Wed, 13 Sep 2023 15:10:45 +0200
(CEST)
from satellite02.sim.rediris.es ([127.0.0.1]) by localhost
(satellite02.sim.rediris.es [127.0.0.1]) (amavisd-new,
port 10026) with ESMTP id Xnckwf7xkfEE for
< [log in para visualizar]>; Wed, 13 Sep 2023 15:10:45 +0200
(CEST)
from limbo.rediris.es (limbo.rediris.es [130.206.1.46]) by
satellite02.sim.rediris.es (Postfix) with ESMTPS id F36768039EB for
< [log in para visualizar]>; Wed, 13 Sep 2023 15:10:42 +0200
(CEST)
(from infoadmin@localhost) by limbo.rediris.es (8.13.8/8.13.8/Submit)
id 38DDAgiq017567; Wed, 13 Sep 2023 15:10:42 +0200 |
Content-Type: |
text/plain; charset=UTF-8; |
X-Amavis-Modified: |
Mail body modified (using disclaimer) -
satellite02.sim.rediris.es |
Delivered-To: |
|
X-Proofpoint-ORIG-GUID: |
xboFabRQG7bPWibVatdYwdPdTJhnVbHO |
Sender: |
|
X-Proofpoint-Spam-Details: |
rule=defaultmarcado_descarta_bulk_notspam
policy=defaultmarcado_descarta_bulk score=0
adultscore=0 bulkscore=0 clxscore=210 suspectscore=0
phishscore=0 priorityscore=0 lowpriorityscore=0
mlxscore=0 spamscore=0 mlxlogscore=999
impostorscore=0 malwarescore=0 classifier=spam
adjust=0 reason=mlx scancount=1
engine=8.19.0-2308100000 definitions=main-2309130106 |
X-Proofpoint-Virus-Version: |
vendor=baseguard
engine=ICAP:2.0.267,Aquarius:18.0.980,Hydra:6.0.601,FMLib:17.11.176.26
definitions=2023-09-13_07,2023-09-13_01,2023-05-22_02 |
X-Proofpoint-GUID: |
xboFabRQG7bPWibVatdYwdPdTJhnVbHO |
Parts/Attachments: |
|
|
===
Para darse de ALTA/BAJA del Boletin OFER-TRABEC utilice el siguiente enlace o pongase en contacto con [log in para visualizar]
https://listserv.rediris.es/cgi-bin/wa?SUBED1=OFER-TRABEC&A=1
===
Para distribuir un convocatoria en OFER-TRABEC, rellene el formulario: https://www.rediris.es/list/sdis/ofer-trabec/form-ofertrabec.php
===
SEGURIDAD: Los enlaces contenidos en este mensaje son seguros y protegidos con reescritura de URL_DEFENSE de Proofpoint
===
---Procedencia:
Institución:Instituto de Neurociencias/ Universidad de Barcelona
Contacto correo-e:[log in para visualizar]
---
The Functional Genomics of Neurodegenerative Diseases group at the Institute of Neurosciences, University of Barcelona, is excited to announce an opportunity for a Master's student to join our research team. We are actively seeking a motivated and talented student in the field of transcriptomics, non-coding RNAs, cell culture, and functional assays to work on an innovative project.
In this Master's thesis project, our goal is to assess the immunogenic potential of human non-coding RNAs in neurodegeneration, with special focus on Huntington’s disease. This research aims to uncover drivers and pathways of chronic immune inflammation, strongly linked with neurodegeneration. Identifying activated pathways and sensors has the potential to define novel therapeutic targets
Objectives :
1. Characterization of the RNA sensing machinery: Utilize state-of-the-art models and human samples of Huntington’s disease to analyze the distribution and levels of expression of RNA sensors that participate in neuroinflammation.
2. Functional assays: Dendritic cell lines will be exposed to non-coding RNAs isolated from Huntington’s disease models and human samples and activation of the immune response will be evaluated.
3. Optimization and Validation: Refine the functional design by evaluating the biochemical properties of immunogenic non-coding RNAs and assessing the impact of pharmacological modulation on activated immune pathways and/or specific ncRNAs
Benefits:
• Gain hands-on experience in immunofluorescence, cell culture, molecular biology
(RNA extraction, qPCR, ELISA assays), and functional assays.
• Utilize state-of-the-art lab equipment and facilities.
• Collaborate with leading neurobiology experts at the Institute of Neurosciences.
• Contribute to high-impact research with potential applications in translational
therapeutic research.
• Present progress in regular Institute of Neurosciences and group lab meetings.
• Receive support and guidance when applying for competitive Ph.D. fellowships
Requirements for candidates:
We are actively seeking students with a degree in biomedicine, biology, biochemistry, or a related discipline. If you are a highly motivated student with an exceptional academic record, a passion for research, and a strong background in molecular biology, we encourage you to apply for this Master’s thesis opportunity, which may lead to a Ph.D. position (after applying for a fellowship). This project will equip you with valuable skills, knowledge, and exposure to advance your career in biomedical research
To apply, please submit the following:
1. Your current curriculum vitae (CV), including your academic transcripts.
2. A cover letter describing your research interests, relevant experience, and career goals.
3. Contact information for two academic references who can provide letters of recommendation.
Please submit your application to Dr. Eulàlia Martí ([log in para visualizar]). Shortlisted candidates will be contacted for an interview.
We look forward to receiving your application and potentially welcoming you to our dynamic research team. Should you have any questions or require further information, please do not hesitate to contact us.
----------------
Información complementaria de la oferta:
The student will be integrated into the research group “Functional Genomics of Neurodegenerative Diseases” (P.I. E. Martí), at the Department of Biomedical Sciences (Universitat de Barcelona, Campus Clinic). Our group belongs to the Institute of Neurosciences that has been awarded with a Maria de Maetzu Excellence Acreditation. At the Institute of Neurosciences internationally recognized research temas are focused on the study of neurodegenerative disorders using multidisciplinary approaches.
https://www.ub.edu/portal/web/dp-biomedicalsciences/genomica-funcional-de-malalties-neurodegeneratives.-ip-eulalia-marti-puig
|